-
1
-
-
65549095761
-
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis
-
McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, et al: Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009; 48: 1364-1371.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1364-1371
-
-
McDonald, J.R.1
Zeringue, A.L.2
Caplan, L.3
Ranganathan, P.4
Xian, H.5
Burroughs, T.E.6
-
3
-
-
72049091520
-
The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease
-
Shale MJ: The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. Br Med Bull 2009; 92: 61-77.
-
(2009)
Br Med Bull
, vol.92
, pp. 61-77
-
-
Shale, M.J.1
-
4
-
-
56549129228
-
The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: A review of the literature
-
Domm S, Cinatl J, Mrowietz U: The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol 2008; 159: 1217-1228.
-
(2008)
Br J Dermatol
, vol.159
, pp. 1217-1228
-
-
Domm, S.1
Cinatl, J.2
Mrowietz, U.3
-
5
-
-
53149084490
-
Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease
-
Wendling D, Streit G, Toussirot E, Prati C: Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease. Joint Bone Spine 2008; 75: 540-543.
-
(2008)
Joint Bone Spine
, vol.75
, pp. 540-543
-
-
Wendling, D.1
Streit, G.2
Toussirot, E.3
Prati, C.4
-
6
-
-
70350513112
-
Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease
-
Marehbian J, Arrighi HM, Hass S, Tian H, Sandborn WJ: Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. Am J Gastroenterol 2009; 104: 2524-2533.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 2524-2533
-
-
Marehbian, J.1
Arrighi, H.M.2
Hass, S.3
Tian, H.4
Sandborn, W.J.5
-
7
-
-
67149101249
-
Infectious complications of biological therapy
-
Haroon N, Inman RD: Infectious complications of biological therapy. Curr Opin Rheumatol 2009; 21: 397-403.
-
(2009)
Curr Opin Rheumatol
, vol.21
, pp. 397-403
-
-
Haroon, N.1
Inman, R.D.2
-
8
-
-
0036294005
-
Shingles following infliximab infusion
-
Baumgart DC, Dignass AU: Shingles following infliximab infusion. Ann Rheum Dis 2002; 61: 661.
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 661
-
-
Baumgart, D.C.1
Dignass, A.U.2
-
9
-
-
70349561257
-
The risk of herpes zoster: Another cost of anti-TNF therapy?
-
Bongartz T, Orenstein R: The risk of herpes zoster: another cost of anti-TNF therapy? Nat Rev Rheumatol 2009; 5: 361-363.
-
(2009)
Nat Rev Rheumatol
, vol.5
, pp. 361-363
-
-
Bongartz, T.1
Orenstein, R.2
-
10
-
-
77949262985
-
Tumor necrosis factor blockade and the risk of viral infection
-
Kim SY, Solomon DH: Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol 2010; 6: 165-174.
-
(2010)
Nat Rev Rheumatol
, vol.6
, pp. 165-174
-
-
Kim, S.Y.1
Solomon, D.H.2
-
11
-
-
67749102110
-
The infectious profiles of anti-tumor necrosis factor agents in a Thai population: A retrospective study at the university-based hospital
-
Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S: The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study at the university-based hospital. Int J Rheum Dis 2009; 12: 118-124.
-
(2009)
Int J Rheum Dis
, vol.12
, pp. 118-124
-
-
Suwannalai, P.1
Auethavekiat, P.2
Udomsubpayakul, U.3
Janvitayanujit, S.4
-
12
-
-
60749125474
-
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents
-
Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, et al: Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009; 301: 737-744.
-
(2009)
JAMA
, vol.301
, pp. 737-744
-
-
Strangfeld, A.1
Listing, J.2
Herzer, P.3
Liebhaber, A.4
Rockwitz, K.5
Richter, C.6
-
13
-
-
79960813514
-
Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster
-
Ito K, Okamoto M, Maruyama F, Handa K, Yamamoto Y, Watanabe M, et al: Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster. Gan To Kagaku Ryoho 2010; 37: 99-102.
-
(2010)
Gan to Kagaku Ryoho
, vol.37
, pp. 99-102
-
-
Ito, K.1
Okamoto, M.2
Maruyama, F.3
Handa, K.4
Yamamoto, Y.5
Watanabe, M.6
-
14
-
-
79954443732
-
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
-
Mishra R, Singh V, Pritchard CH: Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis. Rheumatol Int 2009; 31: 481-484.
-
(2009)
Rheumatol Int
, vol.31
, pp. 481-484
-
-
Mishra, R.1
Singh, V.2
Pritchard, C.H.3
-
15
-
-
79952360597
-
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
-
Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, et al: Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis 2011; 70: 616-623.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 616-623
-
-
Salmon-Ceron, D.1
Tubach, F.2
Lortholary, O.3
Chosidow, O.4
Bretagne, S.5
Nicolas, N.6
-
17
-
-
77955761614
-
Severe pneumonia by aciclovir-resistant varicella-zoster virus during etanercept therapy
-
Manzano V, Ruiz P, Torres M, Gomez F: Severe pneumonia by aciclovir-resistant varicella-zoster virus during etanercept therapy. Rheumatology 2010; 49: 1791-1793.
-
(2010)
Rheumatology
, vol.49
, pp. 1791-1793
-
-
Manzano, V.1
Ruiz, P.2
Torres, M.3
Gomez, F.4
-
18
-
-
67449097800
-
Herpes zoster infection followed by Henoch-Schönlein purpura in a girl receiving infliximab for ulcerative colitis
-
Nobile S, Catassi C, Felici L: Herpes zoster infection followed by Henoch-Schönlein purpura in a girl receiving infliximab for ulcerative colitis. J Clin Rheumatol 2009; 15: 101.
-
(2009)
J Clin Rheumatol
, vol.15
, pp. 101
-
-
Nobile, S.1
Catassi, C.2
Felici, L.3
-
19
-
-
72449193102
-
Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept
-
Tresch S, Trueb RM, Kamarachev J, French LE, Hofbauer GF: Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept. Dermatology 2009; 219: 347-349.
-
(2009)
Dermatology
, vol.219
, pp. 347-349
-
-
Tresch, S.1
Trueb, R.M.2
Kamarachev, J.3
French, L.E.4
Hofbauer, G.F.5
-
20
-
-
79956095925
-
Disseminated cutaneous varicella zoster virus infections during infliximab therapy for Crohn's disease: Case report of two pediatric patients at one institution
-
Kunz AN, Rajnik M: Disseminated cutaneous varicella zoster virus infections during infliximab therapy for Crohn's disease: case report of two pediatric patients at one institution. Clin Pediatr 2011; 50: 559-561.
-
(2011)
Clin Pediatr
, vol.50
, pp. 559-561
-
-
Kunz, A.N.1
Rajnik, M.2
-
21
-
-
79955696994
-
Ustekinumab and herpes zoster
-
Failla V, Nikkels AF: Ustekinumab and herpes zoster. Dermatology 2011; 222: 119-122.
-
(2011)
Dermatology
, vol.222
, pp. 119-122
-
-
Failla, V.1
Nikkels, A.F.2
-
22
-
-
80054956034
-
Protracted herpes zoster and severe postherpetic neuralgia after inadvertant infliximab administration
-
Failla V, Castronovo C, Meex C, Nikkels AF: Protracted herpes zoster and severe postherpetic neuralgia after inadvertant infliximab administration. Eur J Dermatol 2011; 21: 782-783.
-
(2011)
Eur J Dermatol
, vol.21
, pp. 782-783
-
-
Failla, V.1
Castronovo, C.2
Meex, C.3
Nikkels, A.F.4
-
23
-
-
77957100621
-
Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient
-
Buccoliero G, Lonero G, Romanelli C, Loperfido P, Resta F: Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient. New Microbiol 2010; 33: 271-274.
-
(2010)
New Microbiol
, vol.33
, pp. 271-274
-
-
Buccoliero, G.1
Lonero, G.2
Romanelli, C.3
Loperfido, P.4
Resta, F.5
-
24
-
-
60749087331
-
Herpes zoster in the age of focused immunosuppressive therapy
-
Whitley RJ, Gnann JW: Herpes zoster in the age of focused immunosuppressive therapy. JAMA 2009; 301: 774-775.
-
(2009)
JAMA
, vol.301
, pp. 774-775
-
-
Whitley, R.J.1
Gnann, J.W.2
-
25
-
-
0001796683
-
The nature of herpes zoster: A long-term study and a new hypothesis
-
Hope-Simpson RE: The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-20.
-
(1965)
Proc R Soc Med
, vol.58
, pp. 9-20
-
-
Hope-Simpson, R.E.1
-
26
-
-
84857041012
-
Risk of herpes zoster in patients receiving anti-TNF- in the prospective French RATIO registry
-
Serac G, Tubach F, Mariette X, Salmon-Céron D, Ravaud P, Lioté F, et al: Risk of herpes zoster in patients receiving anti-TNF- in the prospective French RATIO registry. J Invest Dermatol 2012; 132: 726-729.
-
(2012)
J Invest Dermatol
, vol.132
, pp. 726-729
-
-
Serac, G.1
Tubach, F.2
Mariette, X.3
Salmon-Céron, D.4
Ravaud, P.5
Lioté, F.6
-
27
-
-
77957274056
-
Incidence and risk of hospitalization due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
-
García-Doval I, Pérez-Zafrilla B, Descalzo MA, Roselló R, Hernandez MV, Gómez-Reino JJ, et al: Incidence and risk of hospitalization due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis 2010; 69: 1751-1755.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1751-1755
-
-
García-Doval, I.1
Pérez-Zafrilla, B.2
Descalzo, M.A.3
Roselló, R.4
Hernandez, M.V.5
Gómez-Reino, J.J.6
-
29
-
-
0025896404
-
Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate
-
Antonelli MA, Moreland LW, Brick JE: Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 1991; 90: 295-298.
-
(1991)
Am J Med
, vol.90
, pp. 295-298
-
-
Antonelli, M.A.1
Moreland, L.W.2
Brick, J.E.3
-
30
-
-
0348109372
-
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: Results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)
-
Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, et al: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 2003; 30: 2563-2571.
-
(2003)
J Rheumatol
, vol.30
, pp. 2563-2571
-
-
Furst, D.E.1
Schiff, M.H.2
Fleischmann, R.M.3
Strand, V.4
Birbara, C.A.5
Compagnone, D.6
-
31
-
-
2342658406
-
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human antitumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial
-
Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, et al: Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human antitumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004; 50: 1400-1411.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 1400-1411
-
-
Keystone, E.C.1
Kavanaugh, A.F.2
Sharp, J.T.3
Tannenbaum, H.4
Hua, Y.5
Teoh, L.S.6
-
32
-
-
11144354315
-
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate
-
Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al: Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004; 50: 1051-1065.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 1051-1065
-
-
Maini, R.N.1
Breedveld, F.C.2
Kalden, J.R.3
Smolen, J.S.4
Furst, D.5
Weisman, M.H.6
-
33
-
-
0034735842
-
Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. Infliximab and methotrexate in the treatment of rheumatoid arthritis
-
Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al: Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594-1602.
-
(2000)
N Engl J Med
, vol.343
, pp. 1594-1602
-
-
Lipsky, P.E.1
Van Der Heijde, D.M.2
St Clair, E.W.3
Furst, D.E.4
Breedveld, F.C.5
Kalden, J.R.6
-
34
-
-
33646464514
-
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience
-
Moreland LW, Weinblatt ME, Keystone EC, Kremer JM, Martin RW, Schiff MH, et al: Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. J Rheumatol 2006; 33: 854-861.
-
(2006)
J Rheumatol
, vol.33
, pp. 854-861
-
-
Moreland, L.W.1
Weinblatt, M.E.2
Keystone, E.C.3
Kremer, J.M.4
Martin, R.W.5
Schiff, M.H.6
-
36
-
-
77952561045
-
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster
-
Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD: Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48:S2-7.
-
(2010)
J Clin Virol
, vol.48
-
-
Gershon, A.A.1
Gershon, M.D.2
Breuer, J.3
Levin, M.J.4
Oaklander, A.L.5
Griffiths, P.D.6
-
37
-
-
2342657877
-
Risk factors for postherpetic neuralgia in patients with herpes zoster
-
Jung BF, Johnson RW, Griffin DR, Dworkin RH: Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-1551.
-
(2004)
Neurology
, vol.62
, pp. 1545-1551
-
-
Jung, B.F.1
Johnson, R.W.2
Griffin, D.R.3
Dworkin, R.H.4
-
38
-
-
35649000409
-
Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: Prospective prognostic study
-
Opstelten W, Zuithoff NP, van Essen GA, van Loon AM, van Wijck AJ, Kalkman CJ, et al: Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain 2007; 132(suppl 1):S52-59.
-
(2007)
Pain
, vol.132
, Issue.SUPPL. 1
-
-
Opstelten, W.1
Zuithoff, N.P.2
Van Essen, G.A.3
Van Loon, A.M.4
Van Wijck, A.J.5
Kalkman, C.J.6
-
39
-
-
80052738296
-
Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor
-
Javed S, Kamili QU, Mendoza N, Tyring SK: Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor. J Med Virol 2011; 83: 2051-2055.
-
(2011)
J Med Virol
, vol.83
, pp. 2051-2055
-
-
Javed, S.1
Kamili, Q.U.2
Mendoza, N.3
Tyring, S.K.4
-
40
-
-
0036909097
-
Oral antivirals revisited in the treatment of herpes zoster. What do they accomplish?
-
Nikkels AF, Piérard GE: Oral antivirals revisited in the treatment of herpes zoster. What do they accomplish? Am J Clin Dermatol 2002; 3: 591-598.
-
(2002)
Am J Clin Dermatol
, vol.3
, pp. 591-598
-
-
Nikkels, A.F.1
Piérard, G.E.2
|